N-甲基哌嗪合成路线

Glaxosmithkline LLC; Aubart, Kelly M.; Benowitz, Andrew B.; Fang, Yuhong; Hoffman, James; Karpinski, Joseph M.; Knox, Andrew Nicholson; Liao, Xiangmin; Qin, Donghui; Shi, Dongchuan; Spletstoser, Jared T.
Patent: US2013/345120 A1, 2013 ;
Location in patent: Page/Page column ;

109-01-3N-甲基哌嗪+

57848-46-1

628326-12-5

参考文献

Nielsen, Simon F.; Larsen, Mogens; Boesen, Thomas; Schonning, Kristian; Kromann, Hasse
Journal of Medicinal Chemistry, 2005 , vol. 48, # 7 p. 2667 - 2677

109-01-3N-甲基哌嗪+

627-18-9

5317-33-9

参考文献

4SC AG
Patent: US2006/142570 A1, 2006 ;
Location in patent: Page/Page column 17 ;

109-01-3N-甲基哌嗪+

627-30-5

5317-33-9

参考文献

Tasler, Stefan; Mueller, Oliver; Wieber, Tanja; Herz, Thomas; Pegoraro, Stefano; Saeb, Wael; Lang, Martin; Krauss, Rolf; Totzke, Frank; Zirrgiebel, Ute; Ehlert, Jan E.; Kubbutat, Michael H.G.; Schaechtele, Christoph
Bioorganic and Medicinal Chemistry, 2009 , vol. 17, # 18 p. 6728 - 6737

109-01-3N-甲基哌嗪

5317-33-9

参考文献

Ratouis; Combes
Bulletin de la Societe Chimique de France, 1959 , p. 576,578

109-01-3N-甲基哌嗪+

107-18-6

5317-33-9

参考文献

Soc. Usines Chim. Rhone-Poulenc
Patent: GB807750 , 1957 ;

109-01-3N-甲基哌嗪+

2765-59-5

58-38-8